NSEAnalysts/Institutional Investor Meet/Con. Call Updates5 Aug 2026 · 5 Aug 2026, 09:43 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Cohance Lifesciences Limited · COHANCE
✦ AI SummaryResults
Cohance Lifesciences Limited has uploaded the audio recording of its conference call for the quarter ended 30 June 2026 on its website.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cohance Lifesciences Limited has informed the Exchange about Link of Recording
Attachments (1)
📄pdf
Download →
SUVENPHARMROHIT_05082026214319_Cohance_concall_audiolink05082026.pdf
View document text
5 August 2026
To To
BSE Limited National Stock Exchange of India Limited
25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543064 Scrip Symbol: COHANCE
Dear Sir/Madam,
Sub: Audio recording of the conference call for the quarter ended 30 June 2026
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, and with reference to our results conference call intimation dated
23 July 2026, that audio recording of the conference call for the quarter ended 30 June 2026 held on
Wednesday, 5 August 2026, has been uploaded on the Company's website and available at the link:
https://www.cohance.com/wp-content/uploads/2026/08/Audio-5Aug26.mp3
This is for your information and record.
Thanking you.
Yours faithfully,
For Cohance Lifesciences Limited
(formerly, Suven Pharmaceuticals Limited)
Sisir k Mishra
Company Secretary & Compliance Officer